ARCHIVES

In Brief: FDA Stops Imports Of Counterfeit Adriamychin; Rosenburg: NIH Pay 25-33% That Of Academia

This article is from The Cancer Letter archive.

Vol. 14 No. 17 | April 22, 1988

Download PDF Visit The Full Archive

Related Articles

Two Papers Evaluate CyberKnife Survival Rates and Tolerability

November 29, 2013

Stand Up To Cancer Co-Founder Laura Ziskin Dies of Complications From Breast Cancer at 61

June 17, 2011

Researchers Identify Five Genes Associated With Melanoma Risk

July 29, 2011

AACR Meeting: Celebrex Studies Show Benign Polyp Reduction, Point To Challenges In Biomarker Validation.

April 14, 2006

Upton Struggling To wrap Up Reorganization Of DCCR Before Next Week’s Meeting Of NCAB

September 28, 1979

FDA Promises No More IND Disruptions Without “Very Valid Reasons,” Nears Agreement With NCI

April 15, 1977